Thanks to recent mergers and acquisitions activity, Globus Medical sits as the second-largest player in the $11 billion spine industry at roughly 20% market share. When the company merged with NuVasive in 2023, it combined two companies with about 9% share each to create a $10 billion market-capitalized entity that has continued to gain share over the past few years. Globus then spent $250 million in 2025 to acquire Nevro and bring spinal cord stimulation into its product portfolio.